# England records 21,129 antibiotic-resistant bloodstream infection episodes in 2025

> UKHSA surveillance recorded 21,129 antibiotic-resistant bacteraemia cases in 2025, 16.8% above 2019, although the annual increase slowed to 3.2%. NHS antibiotic use fell over the period, showing that lower use alone has not reversed the reported resistance burden.

- Canonical URL: https://newsverum.com/en/news/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026
- Publisher: Newsverum
- Section: Health
- Country: United Kingdom
- Published: 2026-11-12T19:01:55+00:00
- Updated: 2026-11-12T19:01:55+00:00
- Event / data period: 2025
- Other editions: [Türkçe](https://newsverum.com/tr/news/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026.md), [العربية](https://newsverum.com/ar/news/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026.md), [Français](https://newsverum.com/fr/news/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026.md), [Español](https://newsverum.com/es/news/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026.md), [Deutsch](https://newsverum.com/de/news/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026.md), [Português](https://newsverum.com/pt/news/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026.md)

The UK Health Security Agency reported 21,129 antibiotic-resistant bacteraemia cases in 2025, equivalent to an average of 406 cases a week. Bacteraemia means bacteria are present in the bloodstream and can be life-threatening. The figure is not a count of every antibiotic-resistant infection in England, nor does it mean all affected people died. It is a surveillance measure for resistant bloodstream infections, and its scope should remain clear when comparing it with other health statistics.

The total was 16.8 per cent higher than the 18,086 cases recorded in 2019. The pace of increase slowed in the latest year: cases rose 3.2 per cent from 20,468 in 2024, compared with a 9.3 per cent rise from 18,732 in 2023. A slower increase is not a decline. The latest annual count remains higher than the previous year and substantially above the 2019 baseline used in the report.

The data show that resistance continued to rise even as antibiotic use in the NHS fell. Total NHS antibiotic consumption decreased 10.7 per cent between 2019 and 2025, from 17.8 to 15.9 defined daily doses per 1,000 inhabitants per day. Private prescriptions dispensed in community pharmacies, which are not included in that NHS measure, fell 20.8 per cent between 2024 and 2025. These measures have different coverage and time periods, and changes in consumption do not translate mechanically into immediate changes in resistant infection rates.

UKHSA also reported an estimate of 2,318 deaths in 2025 among people with resistant Gram-negative bacteraemia, broadly level with 2,399 in 2024. This is a count of deaths among people with the infection, not an estimate that resistance alone caused each death. The agency's summary says further work is underway to quantify costs directly attributable to infection and resistance. A preliminary analysis estimated around 53,400 hospital admissions related to Gram-negative bloodstream infection cost NHS hospitals about £800 million between 2023 and 2024, but that estimate is not a full attribution of cost to resistance.

Age and deprivation patterns point to unequal exposure. Adults over 45 accounted for 89.3 per cent of resistant infection cases, and people over 74 accounted for 49.7 per cent. UKHSA notes that age is associated with multiple health conditions and greater exposure to healthcare and medical interventions. People in the most deprived areas had a 44.2 per cent higher rate of resistant bacteraemia than those in the least deprived areas, at 44.4 compared with 30.8 cases per 100,000 people. Those are population rates, not individual risk predictions.

The report also describes differences by ethnic group and by Integrated Care Board area. The observed rates vary substantially, but the figures do not explain the causes of those differences. UKHSA says it is working with partners to understand them. Differences in health status, care access, testing practices, population structure and exposure may require further analysis before a causal explanation can be made. The release should not be read as evidence that ethnicity itself causes infection or resistance.

The findings reinforce that stewardship is only one part of reducing antimicrobial resistance. Appropriate prescribing can help slow selection pressure, but infection prevention, vaccination, diagnosis, hospital practice and access to effective treatments also matter. UKHSA's own statement says reduced use alone is insufficient. The agency's 2024 to 2029 national action plan provides the policy framework, while the annual surveillance report tracks selected outcomes and prescribing measures.

The verified picture is a persistently elevated number of resistant bloodstream infections, a slower year-on-year increase, lower reported NHS antibiotic consumption and marked differences across age and deprivation groups. The data do not establish why each trend changed or how much of the death and hospital cost burden is directly attributable to resistance. Future releases should be assessed against consistent definitions and coverage, with attention to both infection prevention and responsible antibiotic use.

## Data

### Key reported figures

Selected figures transcribed from the cited primary source.

Methodology: Figures retain the source's stated period, population, scope and definitions. Announced targets, estimates, forecasts and upper bounds are labeled by basis. No missing value is inferred.

| label | value | unit | period | basis | period_start |
|---|---|---|---|---|---|
| Antibiotic-resistant bacteraemia cases | 21129 | count | 2025 | observed |  |
| Change in resistant bacteraemia cases from 2024 | 3.2 | percent | 2025 | observed | 2024 |
| NHS antibiotic use change from 2019 to 2025 | -10.7 | percent | 2025 | observed | 2019 |
| Higher resistant bacteraemia rate in most deprived areas | 44.2 | percent | 2025 | observed |  |

Sources: <https://www.gov.uk/government/news/over-400-antibiotic-resistant-infections-each-week-in-2025>, <https://www.gov.uk/government/publications/english-surveillance-programme-for-antimicrobial-utilisation-and-resistance-espaur/espaur-report-2025-to-2026-chapter-2-antimicrobial-resistance-amr> · Download data: [JSON](https://newsverum.com/api/v1/articles/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026/data/reported-figures?lang=en&format=json) · [CSV](https://newsverum.com/api/v1/articles/england-antibiotic-resistant-bacteraemia-2025-surveillance-2026/data/reported-figures?lang=en&format=csv)

## Sources

- [UK Health Security Agency, Over 400 antibiotic-resistant infections each week in 2025](<https://www.gov.uk/government/news/over-400-antibiotic-resistant-infections-each-week-in-2025>) (Source checked: 2026-11-12; Published: 2026-11-12)
- [UK Health Security Agency, ESPAUR report 2025 to 2026, Chapter 2: Antimicrobial resistance](<https://www.gov.uk/government/publications/english-surveillance-programme-for-antimicrobial-utilisation-and-resistance-espaur/espaur-report-2025-to-2026-chapter-2-antimicrobial-resistance-amr>) (Source checked: 2026-11-12; Published: 2026-11-12)

---

Cite the canonical URL above. [Editorial standards and corrections](https://newsverum.com/en/editorial)
